Business
Natural Harmony Foods Inc. Announces New Strategic Direction and Sets the Stage for a Revolution In Healthcare and Wellness
Natural Harmony Foods Inc. Announces New Strategic Direction and Sets the Stage for a Revolution In Healthcare and Wellness.
About this update from Synbio International Inc.
[{"type":"text","content":"NEW YORK, NY / ACCESSWIRE / September 19, 2023 / Publicly-held Natural Harmony Foods, Inc. (OTC PINK:NHYF) (the Company) announces that following the change of control to Mr. Claudio Solitario, announced recently, the Company is now on a transformative path, signaling a compelling strategic direction. The Company's transition under Claudio's leadership signifies a dynamic shift towards innovation and growth, underpinned by his extensive knowledge and experience in medical technology and intellectual property development and commercialization. Mr. Claudio SolitarioThe Power of Artificial Intelligence Solutions in HealthcareCentral to NHYF's transformation is its commitment to harness the power of Artificial Intelligence (AI) in healthcare. AI-driven medical technology is set to revolutionize the field, promising faster, more accurate diagnoses; personalized treatment plans, and improved patient outcomes. AI's potential to transform the medical field is undeniable, offering promise of more efficient and effective healthcare for all. The Company will be at the forefront of this exciting advancement in medical technology focusing on the development of AI-powered screening methods and to this end, is forming strategic partnerships in an effort to co-develop the following:Life-Saving Innovation: AI-based intellectual property for the fast and early identification of life threatening pulmonary embolisms using CAT scan detection software. A pulmonary embolism is a medical emergency; it may be fatal causing death. Pulmonary embolism affects around 900,000 people in the U.S. every year1. The AI-powered technology aims to improve the radiologic processing time and reading performance during emergency evaluations.Facial Analysis to objectively screen for PTSD: AI-based facial analysis technology to objectively screen for post-traumatic stress disorder. The technology will analyze and interpret facial data, the result of which will be seen immediately by the user - with an option of sending it to their medical practitioner. This innovative approach will empower individuals and their healthcare providers to proactively manage mental health. The incidence of mental illness in the USA is well known; and the cost is estimated at $300Billion annually2. A quick and objective assessment of PTSD is required by patients and healthcare professionals a...